About Xcelience
Xcelience is a company based in Tampa (United States) founded in 1997 was acquired by Capsugel in December 2015. Xcelience operates in a competitive market with competitors including Akums, Jubilant Life Sciences, Unither, Recipharm and Nectar Lifesciences, among others.
- Headquarter Tampa, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Xcelience
Detailed funding history for Xcelience
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Xcelience
Xcelience has secured backing from 1 investor. Prominent investors backing the company include Capsugel.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Dosage forms are delivered for preclinical, clinical, and commercial supply.
|
Locked | Locked | Locked |
Investor details for Xcelience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Xcelience
Investment portfolio details for Xcelience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Xcelience
Detailed financials for Xcelience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Xcelience Comparisons
Peer comparison for Xcelience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Xcelience
Xcelience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Akums, Jubilant Life Sciences, Unither, Recipharm and Nectar Lifesciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
Detailed competitors of Xcelience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Xcelience
Complete news archive for Xcelience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Xcelience
Xcelience was founded in 1997.
Xcelience is headquartered in Tampa, United States. It is registered at Tampa, Florida, United States.
Xcelience was founded in 1997 in Tampa, United States, and operates as a contract development and manufacturing organization in the pharmaceutical sector. Early-phase small molecule development is specialized in, with services encompassing preformulation, analytical testing, formulation development, stability management, GMP clinical manufacturing, small-scale commercial production, and clinical supplies packaging along with logistics for Phase I to III trials.
Xcelience's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Xcelience has 1 investor. Key investors include Capsugel.